Navigation Links
Cord Blood America Announces Preferred Pricing for Blue Cross of Northeastern Pennsylvania Members
Date:8/18/2009

SANTA MONICA, Calif. and WILKES-BARRE, Pa., Aug. 18 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today the participation of its subsidiary CorCell Companies, Inc., in the MyHealth Mart Value-Added Discount Program for members of Blue Cross of Northeastern Pennsylvania to access cord blood banking services at a preferred price. The MyHealth Mart Value-Added Discount Program is administered by AllOne Health Management Solutions, Inc. for Blue Cross of Northeastern Pennsylvania.

"Participation in this program allows CorCell to bring the knowledge and awareness of the significant value of storing umbilical cord blood to Blue Cross of Northeastern Pennsylvania members," said Matt Schissler, CorCell's CEO. "We are pleased that we can offer this important life-saving service to their members at a discounted price."

Cord blood stem cells may be used today to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies with many additional uses currently under investigation in clinical trials and in research and development. Previously the umbilical cord, which contains a rich store of stem cells, had been thrown away at birth.

About AllOne Health Management Solutions, Inc.

AllOne Health Management Solutions (HMS) is a national population health management company headquartered in Wilkes-Barre, Pennsylvania. The company offers a comprehensive suite of products and services that helps organizations manage the problem of rising health care costs by empowering individuals to take personal accountability for their health. AllOne Health Management Solutions is part of AllOne Health Group, a company whose affiliates share a common mission: to promote health and wellness, support accessible health care, bring health care costs under control, and improve the productivity and safety of the workforce.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

    Matthew L. Schissler
    Chairman & CEO
    Cord Blood America, Inc.
    888.882.CORD (2673)
    for consumer information: www.corcell.com
    for investor relations: www.cordblood-america.com
    e-mail: mls@cordblood-america.com


'/>"/>
SOURCE Cord Blood America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
2. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
3. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
4. The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes
5. CDC Awards NATT Funding to Improve Blood Clot Awareness
6. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
7. Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis
8. Blood Donations in U.S. Testing Positive for Chagas Disease
9. One of Nations Oldest Blood Services Providers Turns to Sysmex America
10. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
11. AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company ... A financing and note conversion to commercialize its Cool ... is focused on developing products that are simultaneously profitable ... million in the last 18 months. This latest round ... Bridge Venture Partners. The company,s primary ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a fundamental challenge ... to full-size tissues, bones, even whole organs to implant in people to treat ... deep into the developing tissue. , Current bioengineering techniques, including 3-D printing, ...
(Date:3/22/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused ... announced today that Dr. Miriam Kidron , ... titled, "Oral Insulin for Diabetes Treatment: Bypassing the ... and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT ... (the "Company" or "Propellon"), a start-up created by ... anti-cancer therapeutics. FACIT,s investment, combined with non-dilutive capital, ... program. The seed funding enables Propellon to accelerate ... the Company for financing and/or entering a strategic ...
Breaking Biology Technology:
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
(Date:3/6/2017)... 6, 2017 Mintigo , the ... announced Predictive Sales Coach TM , its new ... intelligence into Salesforce. This unique AI application will ... organizations with deep knowledge of their customers and ... engagement. Predictive Sales Coach extends Mintigo,s existing customer ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
Breaking Biology News(10 mins):